Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05050591 · ClinicalTrials.gov registry record · NA

Evaluating the Clinical Effectiveness of a Patient-specific Silicone Stent

A NA study of Pulmonary Disease, Chronic Obstructive, sponsored by VisionAir Solutions.

Active
Registry status
NA
Development phase
20
Enrollment target
2
Study locations

NCT05050591 is a NA study of Pulmonary Disease, Chronic Obstructive that is active but no longer recruiting, run by VisionAir Solutions. The registered enrollment target is 20 participants, below the 1,044-participant average among 74 other Pulmonary Disease, Chronic Obstructive trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05050591, a NA study of Pulmonary Disease, Chronic Obstructive, is active but no longer recruiting, sponsored by VisionAir Solutions.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
2
Study locations

Study Summary

The goal of the trial is to establish a method, material, and patient-specific stent design that will last longer, fit better, and cause less trauma to the airway and the patient.

Interventions

  • DEVICE Patient-Specific Silicone Airway Stent

Study Locations (2)

Minnesota

  • Mayo Clinic - Rochester

Ohio

  • Pulmonary Medicine - Cleveland

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-08-05
Est. Completion 2025-07
Phase NA

Sponsor

VisionAir Solutions

1 total trials

What the Registry Record Tells You About NCT05050591

The ClinicalTrials.gov registry entry for NCT05050591 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,044-participant average among 74 other Pulmonary Disease, Chronic Obstructive trials with a reported enrollment target (98% lower). The listed sponsor is VisionAir Solutions, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pulmonary Disease, Chronic Obstructive appearing as the primary indexed condition, and to 1 intervention - of which Patient-Specific Silicone Airway Stent is the first listed.

NCT05050591 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, Ohio.

Frequently Asked Questions

What is clinical trial NCT05050591 about?

NCT05050591 is a clinical study titled "Evaluating the Clinical Effectiveness of a Patient-specific Silicone Stent". The goal of the trial is to establish a method, material, and patient-specific stent design that will last longer, fit better, and cause less trauma to the airway and the patient.

What is the current status of trial NCT05050591?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-08-05. Estimated completion is 2025-07.

What conditions does trial NCT05050591 study?

This clinical trial studies the following conditions: Pulmonary Disease, Chronic Obstructive.

What interventions are being tested in trial NCT05050591?

The interventions under investigation include: Patient-Specific Silicone Airway Stent (DEVICE).

Who is sponsoring clinical trial NCT05050591?

This trial is sponsored by VisionAir Solutions, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05050591 being conducted?

This trial has 2 study locations across Minnesota, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pulmonary Disease, Chronic Obstructive

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.